Results 41 to 50 of about 9,286 (149)
Immunity, Inflammation and Disease, 2021 Objective Cytomegalovirus (CMV) infections are correlated with complications following heart transplantation (HTx) and impaired outcome. The impact of a serologic mismatch between donor and recipient and the necessity of prophylactic virostatic ...
Moritz B. Immohr +10 more
doaj +1 more source
Transplant Infectious Disease, EarlyView.In this retrospective cohort of kidney transplant recipients, no herpes zoster cases occurred during 398 vaccinated person‐years, compared with 78 cases (16.4 per 1000 person‐years) among unvaccinated recipients. These findings support a protective association of the recombinant zoster vaccine (RZV) and reinforce current recommendations for ...
Kyungsup Kwon +12 more
wiley +1 more source
Impact of Letermovir on Voriconazole Concentrations in Lung Transplant Patients
Transplant Infectious Disease, EarlyView.Concomitant letermovir was associated with lower voriconazole exposure and reduced attainment of commonly used efficacy thresholds in lung transplant recipients. Routine therapeutic drug monitoring after letermovir initiation is recommended, and empiric voriconazole dose escalation may be needed to avoid subtherapeutic exposure. ABSTRACT Background The
Leah Georgiades +6 more
wiley +1 more source
Frontiers in PharmacologyBackgroundMaribavir and valganciclovir are pharmacotherapeutic options utilized in the management of cytomegalovirus (CMV) infection post-transplantation.
Haolin Teng +3 more
doaj +1 more source
Transplant Infectious Disease, EarlyView.This multicenter cohort study comparing real‐life preventive strategies shows that in a setting with CMV surveillance after prophylaxis, 3 months of antiviral prophylaxis seems adequate to prevent CMV disease in non‐lung solid organ transplant recipients, whereas lung transplant recipients may benefit from longer duration of prophylaxis.
Anja Lindis Dahl +13 more
wiley +1 more source
Transplant Infectious Disease, EarlyView.Letermovir use for active R/R CMV infection was associated with treatment‐emergent resistance in approximately one‐third of patients, particularly in those with high baseline viral loads and delayed virological response. These findings support careful patient selection, close virological monitoring, and early resistance testing.
Tobias Veit +11 more
wiley +1 more source
Journal of Medical Virology, Volume 98, Issue 10, October 2026.ABSTRACT Patients in intensive care units (ICU) under mechanical ventilation, particularly those with SARS‐CoV‐2 infection, are highly susceptible to Herpes simplex virus (HSV) reactivation. Given the lack of data on the SARS‐CoV‐2 Omicron and Delta variants, this study aimed to assess the prevalence of pulmonary HSV reactivation in mechanically ...
Bastien Zarlenga +14 more
wiley +1 more source
Cytomegalovirus retinitis treated with valganciclovir in Wegener’s granulomatosis
Clinical Ophthalmology, 2012 Yoshiaki Kabata1, Genichiro Takahashi1, Hiroshi Tsuneoka21Department of Ophthalmology, Jikei University School of Medicine, Katsushika Medical Center, Katsushika, Tokyo, Japan; 2Department of Ophthalmology, Jikei University School of Medicine, Minato ...
Kabata Y, Takahashi G, Tsuneoka H
doaj
Successful Management of Persistent DRESS with Tofacitinib: Two Case Reports
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Marc Hernández‐Santacana +5 more
wiley +1 more source
Acta Paediatrica, Volume 115, Issue 10, Page 2191-2199, October 2026.ABSTRACT Aim Neonates discharged home on medications remain at risk of medication errors. The PADDINGToN programme previously developed parent co‐designed resources to support safer medication administration following discharge. The aim of this study, PADDINGToN‐2, is to evaluate the feasibility of recruiting and retaining parents in a study assessing ...
S. Giva +9 more
wiley +1 more source